Shareholders that lost money on GoodRx Holdings, Inc.(GDRX) should contact The Gross Law Firm about pending Class Action - GDRX

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of GoodRx Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's revenue sources and business operations [1][2]. Group 1: Allegations - The complaint alleges that during the class period from September 23, 2022, to November 8, 2022, GoodRx misrepresented its reliance on Kroger, which accounted for nearly 25% of its total prescription transactions revenue despite representing less than 5% of pharmacies accepting GoodRx discounts [1]. - It is claimed that Kroger had the ability to unilaterally stop accepting GoodRx discounts, which could significantly impact GoodRx's revenue from Kroger pharmacies [1]. - The allegations suggest that the defendants' statements regarding GoodRx's business, operations, and future prospects were materially false and misleading, lacking a reasonable basis [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of GoodRx during the specified class period are encouraged to register for the class action by June 21, 2024, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].